Buprenorphine prescribing now available to all DEA-registered physicians
From the AMA: In a major advance for patients with opioid use disorder (OUD) and efforts to end the epidemic of drug overdose and death, the Consolidated Appropriations Act of 2023 eliminated the requirement for physicians to obtain a waiver from the Drug Enforcement Administration (DEA) to prescribe buprenorphine for OUD treatment.
